|Home | Speakers | Agenda | Satellite Course | Venue | Delegates | Sponsors | Media | Register|
Confirmed speakers include:
Professor of Allied Health and Medicine
Anglia Ruskin University, UK
Stephen Bustin obtained his PhD in molecular genetics from Trinity College, University of Dublin and is currently Professor of Allied Health and Medicine at Anglia Ruskin University in the UK. He has authored numerous papers, review articles and book chapters aimed at improving the reproducibility and robustness of real-time PCR, and has the “A-Z of quantitative PCR” (2004), “The PCR Revolution” (2011) and “PCR Technology” (2013, with Tania Nolan). Professor Bustin was an expert witness advising the UK High Court on qPCR technology in the Measles Mumps Rubella (MMR) vaccine - Autism class action as well as at the MMR trial in Washington DC in 2007. He led an international consortium developing the MIQE guidelines for the use and reporting of qPCR (2009). Professor Bustin has extensive editorial involvements as Editor-in-Chief, Biomolecular Detection and Quantification (Elsevier) , Editor-in Chief (Gene Expression), International Journal of Molecular Sciences, and is a member of the editorial boards of “Nature Scientific Reports”, “Gene Regulation and Systems Biology” and “ Biomarkers in Medicine”.
Senior Scientist, Department of Pathology
University of Gothenburg, Sweden
Anders Ståhlberg, Associate Professor, is working as principal investigator at the Cancer Center, Sahlgrenska Academy, University of Gothenburg in Sweden. He has a PhD in molecular biotechnology and gene expression profiling and has performed two post-doc periods working with human embryonic stem cells, stem cell properties of astrocytes and human sarcomas. Anders primary research interest is to understand molecular mechanisms in tumor initiation, tumor development and stem cell differentiation. The research are focused on sarcomas caused by specific fusion oncogenes, but other tumor types are also studied. He has developed several strategies for gene expression profiling, especially at the single-cell level. Anders is also co-founder of TATAA Biocenter, Gothenburg, Sweden.
Principle Investigator, Department of Anatomy, Embryology & Physiology, Academic Medical Centre
Amsterdam University, The Netherlands
Jan M Ruijter trained as a medical biologist and worked in endocrinology, neurobiology, ophthalmology and embryology. He is currently appointed as principle investigator in the department of Anatomy, Embryology & Physiology (Academic Medical Centre, Amsterdam, the Netherlands) where he is heading a research group studying the relation between gene expression and the development of the heart with molecular, image analysis and 3D reconstruction techniques. The statistical analysis of research data resulted in the development of the LinRegPCR program for the analysis quantitative PCR data based on PCR efficiency values derived from amplification curves (http://LinRegPCR.nl).
Director, Real-Time PCR Research & Diagnostic Core Facility
University of California, Davis, USA
Dr. Hodzic graduated from the Veterinary school at University of Sarajevo, then obtained Master degree and a Ph.D. degree that laid a foundation in the area of Microbiology and molecular biology. As a postdoctoral fellow at Yale, Dr. Hodzic research focused on investigating the interaction of Borrelia burgdorferi and Anaplasma phagocytophilum, with tick vectors and mammalian hosts, using animal models. In 1997 he got a faculty position at the Center for Comparative Medicine, at University of California at Davis. Currently he is serving as a Director of the Real-Time PCR Research and a diagnostic Core Facility at UC Davis, School of Veterinary Medicine. During his career Dr. Hodzic collaborated with other researchers, and produced numerous peer-reviewed publications from each project. Well grounded in academics, in research, and in experimental skills, Dr. Hodzic has demonstrated evidence of accomplishment, productivity, independence, collaboration, expertise and scientific abilities in the area of Microbiology and molecular biology.
Group Leader/CNRS Researcher
CNRS/Université Paris-Descartes, France
After graduation as a Molecular Toxicologist (Paris-Descartes), Dr Taly (Abecassis) performed her PhD research at the Center of Molecular Genetics (CNRS, Gif-sur-Yvette, France) on applications of combinatorial methods (generally used for proteins directed evolution) to the study of the functional plasticity of human Cytochromes P450. She joined Andrew Griffiths’ group in 2003, in the Medical Research Council in Cambridge (UK), to work on in vitro compartmentalization of biological and chemical reactions in emulsion droplets and participated to the development of High-throughput selection procedures of double-emulsions by FACS. In 2005, she integrated the Laboratory of Biological Chemistry directed by Prof. Andrew Griffiths in the ISIS institute (Université de Strasbourg) as a permanent CNRS researcher in 2005 to work on HTS procedures using droplet-based microfluidics. Since 2008, she developed droplet-based digital procedures for Cancer diagnosis. Recently, her team developed a highly sensitive quantitative procedures for the detection of Cancer Biomarkers in droplets in a collaboration involving the clinical laboratory of Prof. P. Laurent-Puig (European Georges Pompidou Hospital, University Paris-Descartes), the team of Dr J.-C. Baret (Max Plank Institute) and Raindance Technologies (US). She is now Group Leader in the university Paris-Descartes. Her research is dedicated to the clinical validation of the developed droplet-based procedures for the non-invasive detection of Cancer biomarkers, the highlighting of new Cancer Biomarkers and the development of original tools and procedures for their detection with applications in personalized medicine, cancer recurrence detection and cancer diagnostics.
Professor of Biochemical Engineering, Department of Chemistry and Applied Biosciences, ETH Zürich
Professor of Bioengineering, MRC Clinical Sciences Centre, Imperial College London
Andrew is currently Professor of Biochemical Engineering in the Department of Chemistry and Applied Biosciences at ETH Zurich. He is also Professor of Bioengineering at the MRC Clinical Sciences Centre, Imperial College London.
He obtained a 1st Class Degree in Chemistry and PhD in Molecular Photophysics from Imperial College London in 1995 and subsequently held a Postdoctoral Fellowship in the Department of Chemistry at the University of California, Berkeley.
His research interests cover a broad range of activities in the general area of microfluidics and nanoscale science. Primary specializations include the development of microfluidic devices for high-throughput biological and chemical analysis, ultra-sensitive optical detection techniques, nanofluidic reaction systems for chemical synthesis, novel methods for nanoparticle synthesis, the exploitation of semiconducting materials in diagnostic applications, the development of intelligent microfluidics and the processing of living organisms.
Andrew has given approximately 250 invited lectures at international conferences and universities including 60 plenary or keynote lectures, has published 210 papers in refereed journals, and co-authored two books. He is also co-founder of Molecular Vision Ltd, an Imperial College spin-out company developing low-cost diagnostic devices for use in the doctor's surgery and in the home. Science originating from the deMello group has been recognized through the award of the 2002 SAC Silver Medal (Royal Society of Chemistry), the 2009 Clifford Paterson Medal from The Royal Society, the 2009 Corday Morgan Medal (Royal Society of Chemistry), the 2007 Clark Memorial Lectureship (California State University) and 2012 Pioneers of Miniaturisation Award (Dow Corning)
Associate Chair, Surgical Research, Associate Professor of Surgery
Boston University, USA
Tony E. Godfrey, PhD, Associate Chair for Surgical Research and Associate Professor of Surgery, Boston University School of Medicine, earned a bachelor’s of science degree in biochemistry from Brunel University in England, followed by a doctorate in molecular biology and biochemistry, also from Brunel. He attended the University of California, San Francisco, for postdoctoral fellowships followed by faculty appointments at the University of Pittsburgh, Mount Sinai Hospital, NY, and the University of Rochester Medical Center in Rochester, NY.
Dr. Godfrey’s research is focused on cancer genetics and molecular pathology. Research projects use state-of-the-art genetic and genomic approaches to address clinical needs in the areas of cancer diagnosis, prognosis and therapy. Currently the major focus of Dr. Godfrey’s research is on Barrett’s oesophagus and oesophageal adenocarcinoma. The Godfrey lab works closely with translational research teams comprised of surgeons, pathologists and oncologists in order to develop new molecular approaches to cancer detection, staging and treatment.
Senior Lecturer in Allergy
Kings College London, UK
Dr Victor Turcanu is a senior lecturer in allergy at King’s College London where he leads the Paediatric Allergy and Immunological Tolerance Laboratory in the Division of Asthma, Allergy and Lung Biology and also holds a honorary clinical lecturer position with Guy’s and St. Thomas’ NHS Foundation Trust.
Dr Turcanu is a specialist physician in internal medicine and was awarded a PhD degree in Immunology and Immuno-pharmacology at the Louis Pasteur University, Strasbourg, France. He also carried out medical research projects at the Max-Planck-Institut für Immunbiologie (Freiburg, Germany), at the Universities of Tokyo and Yokohama (Japan) and at the University of Bristol and Imperial College London.
Dr. Turcanu's main research interests concern the immunological treatment of allergies and autoimmune diseases. His research is currently supported by grants from the Food Standards Agency (UK) and from the Immune Tolerance Network and the National Peanut Board (USA).
Professor of Agriculture
University of Curtin, Australia
I was trained in biochemistry at the University of Bristol, UK and obtained a PhD in 1982 on chlorophyll biosynthesis. After a EMBO postdoctoral fellowship (1982-84) at the Carlsberg Laboratory, Denmark I accepted a lectureship at the University of East Anglia and began a research program in fungal plant pathology focussing on Cladosporium fulvum. In 1996 I returned to the Carlsberg Laboratory as the Head of Department and Professor of Physiology. I initiated large scale genomics of powdery mildew, developed transient assay techniques to test antifungal genes and expanded metabolomics analyses of infection processes. Subsequently, I was appointed to lead the Australian Centre for Necrotrophic Fungal Pathogens (ACNFP) at Murdoch University, Australia. In 2010 I moved the ACNFP to Curtin University. The main focus was cereal necrotrophic pathogens and the development of the effector model. New research areas in fungicide resistance and barley mildew have been developed. Recently, Curtin and the GRDC have established a bilateral research program called the Centre for Crop and Disease Management. The scope includes agronomic and economic aspects of crop disease management and a new program in Sclerotinia.
Charlotte Guldborg Nyvold
Associate Professor, HemoDiagnostic Laboratory
Aarhus University Hospital, Denmark
Charlotte Guldborg Nyvold is Associate Professor at Aarhus University Hospital in Denmark. She holds a Master of Science in Chemistry and Biotechnology from Aarhus University and has completed her Ph.D. studies at the Department of Clinical Immunology at the National University Hospital Rigshospitalet in Copenhagen.
For the past 20 years she has been working with quantification of minimal residual disease in haematological cancers using qPCR. She is a part of the diagnostic unit at the Molecular Genetic Section, Department of Haematology at Aarhus University Hospital where haematological neoplasms are being diagnosed and monitored using molecular biomarkers. Her research is presently focused on the characterisation of new molecular markers in monoclonal B-cell malignancies directed towards personalized diagnosis and prognosis.
Assistant Professor of Microbiology
University of Burgos, Spain
Dr. David Rodríguez-Lázaro is a Doctor in Veterinary Medicine (DVM), specialised in Food Science (BSc and MSc) and Molecular Microbiology (PhD). He is senior scientist at ITACyL and assistant Professor of Microbiology at the University of Burgos. He has performed research stays in the Danish Institute for Food and Veterinary Research (Denmark), University of Prague (Czech Republic), the Food and Environmental Research Agency (UK), and the University of Bristol (UK). He was a Leverhulme visiting Professor in the Institute of Advanced Sciences in the University of Bristol during the years 2004 and 2005 and Marie Curie Research Fellow in the Faculty of Medical and Veterinary Sciences in the University of Bristol (UK) until 2.007. His research interest is focused on the development of emergent food preservation processes and their effects in the virulence and the establishment of reliable, quantitative molecular strategies for detection of important food-borne pathogens from environmental sources and various types of foodstuffs. He has participated in a number of coordinated European and Spanish projects such as PROMISE, BASELINE, VITAL, FOOD-PCR, SACROHN, and MONI-QA, having established active links with the leading European research groups working in Food Safety. He has published more than 75 international research papers and book or book chapters regarding to Food Safety. He is currently member of the editorial board of “Applied and Environmental Microbiology”, “International Journal of Food Microbiology” and “Food and Environmental Virology”, and the editor-in-chief of the Journal “Food Analytical Methods” edited by Springer.
Assistant Professor of Pathology ; Director, Molecular Pathology
Northwestern University/Ann and Robert H. Lurie Children's Hospital of Chicago, USA
Larry Jennings, MD, PhD, D(ABHI), FCAP, is an Assistant Professor in the Department of Pathology and Laboratory Medicine Northwestern University's Feinberg School of Medicine. He is board-certificated in anatomic and clinical pathology, molecular genetic pathology, histocompatibility and immunogenetics. He is director of HLA and molecular diagnostic laboratories at Ann and Robert H. Lurie Children’s Hospital of Chicago. Dr. Jennings chairs the Molecular Oncology Resource Committee for the College of American Pathologists and has overseen the Minimal Residual Disease external quality assessment survey for the past 7 years. His work with digital PCR has focused on clinical applications of the technology and includes publications on the use of droplet digital PCR for the detection of and quantification of microchimerism and minimal residual disease.
Marcos Egea Gutiérrez-Cortines
Professor of Genetics
Marcos Egea-Cortines. Studied Biology at the University of Murcia (Spain). He did his PhD at Ben-Gurion University (Israel) and post-doctoral studies at the Technion, Israel Institute of Technology. He was a post-doctoral Fellow of the Max-Planck Society (Plant Breeding Cologne). Associate professor of Genetics at the Universidad Politécnica de Cartagena, and Vicedirector of the Institute of Plant Biotecnology. He was a visiting professor at Purdue University (USA). Works in developmental genetics and is interested in regulation of growth and plant products by the genome and its interaction with the environment. The lab has a strong interest in the development of molecular technologies and methods related to Q-PCR, NGS, and automation of sample acquirement.
Leader Research Field "Innovative Detection Technologies and Assay Designs"
Department of Plant Biotechnology
Fraunhofer Institute of Molecular Biology and Applied Ecology Aachen, Germany
Florian Schröper studied biology at RWTH Aachen University in Germany including an internship at the Fraunhofer Center for Molecular Biotechnology in Newark, Delaware, USA where he was involved in several projects focusing on molecular farming and plant biotechnology. He graduated in 2005 and subsequently started his PhD at the Institute of Bio- and Nanosystems at the Researchcenter Jülich, Germany. In his thesis he worked on strategies for functional protein immobilization to electrode surfaces for bioelectronical applications. He finished his PhD in 2009. Since then he worked at the Fraunhofer Institute of Molecular Biology and Applied Ecology in Aachen. As Postdoc he has been working in the department of plant biotechnology focusing on the development of different analytical approaches. Since 2012 he is responsible for the research field "Innovative Detection Technologies and Assay Designs" were he has established different immunological, qPCR and Next Generation Sequencing based detection and screening approaches for agricultural and plant biotechnological applications.
Senior Principal Research Scientist, Preventative Health Flagship
Commonwealth Scientific and Industrial Research Organisation, Australia
Dr Molloy has over 30 years’ experience in molecular and cell biology and genetics, with a particular focus on epigenetics and the regulation of gene expression. He has made significant contributions to the development of technologies for analysis of DNA methylation, including bisulphite sequencing, selective amplification methods and novel methods of genome-wide analysis. As Leader of Colorectal Cancer Diagnostics within CSIRO’s Preventative Health Flagship, his major research role has been in identification and validation of molecular biomarkers and optimisation of methods for early detection of colorectal cancer. A set of DNA methylation biomarkers arising from this work has undergone validation in a large clinical trial. A diagnostic assay base on this collaborative program is being commercialised by partner Clinical Genomics Pty Ltd with launch in mid 2014.
Jette Feveile Young
Aarhus University, Denmark
Jette Feveile Young is an Associate Professor with the Institute of Food Science at Aarhus University where she is scientific leader for the Differentiated and Biofunctional Food Group. She holds a Master of Food Science from the former Royal Veterinarian Agricultural University (now University of Copenhagen) as well as a PhD in Photo Biology from the University of Wales. She returned to Denmark in 1996 to take a Post Doc position at the Institute of Human Nutrition at Copenhagen University investigating the nutritional effects of naturally occurring antioxidants.
She now pursues her research career with scientific focus on meat quality in relation to feeding, stress and slaughter conditions and partly on the biological functionality of food components using in vitro cell based models.
Associate Professor and Director
Texas A&M Agrilife Synthetic and Systems Biology Innovation Hub, Texas A&M University, USA
Dr. Joshua Yuan is an Associate Professor at Department of Plant Pathology and Microbiology and the Director for Texas A&M Agrilife Synthetic and Systems Biology Innovation Hub in Texas A&M University. He received his Ph.D. degree with focus areas on Functional Genomics (Major) and Statistics (Minor) from the University of Tennessee (2007). He also holds an M.S. in Plant Sciences from the University of Arizona (2001) and a B.S. in Biology (Major) and International Economics (Minor) from Fudan University (1997). Dr. Yuan developed an integrated and multidisciplinary research program centralized around systems and syntehtic biology, where latest ‘omics’ technologies were employed to address the challenging biological questions in biofuel development and to guide the biodesign of microbes and plants for the production of fuels, chemicals and nutriceuticals. Dr. Yuan also synergized the teaching and research with extensive scholarship and service activities in bioenergy and synthetic biology by serving as international conference committee chairs, journal associate editors, board of directors for scholar society, and scientific advisors for start-up companies in Texas and beyond. Dr. Yuan’s article on statistical analysis of real time PCR has been cited over 700 times and has been the all-time most viewed article in BMC bioinformatics (>135,000 views).
Dev Mani Pandey
Associate Professor, Department of Biotechnology
Birla Institute of Technology, Mesra, Ranchi, Jharkhand, India
Dr. Dev Mani Pandey completed his Ph. D. in Plant Physiology and Biochemistry from Chaudhary Charan Singh, Haryana Agriculture University, Hisar, India. He was Post-Doctoral Fellow in Republic of South Korea and worked in the areas of Plant Molecular Biology and Functional Genomics. He was also invited as Consultant to Plant Breeding, Genetics and Biotechnology, IRRI, Los Banos, Philippines.
Dr. Pandey has presented his research findings in various National and International Symposia, Conferences and Congress as well as organized International Symposium successfully. He has published several research papers in peer reviewed journals. He is the Principal Investigator of Sponsored projects as well as Guide of many Ph. D. Scholars. His research areas and scientific expertise includes molecular biology, functional genomics, stress physiology and bioinformatics approaches on crop plants using recent biotechnological tools.
Canadian Grain Commission, Canada
Tigst Demeke joined the Canadian Grain Commission (CGC) as a research scientist in April 2001. He received his Ph.D from Colorado State University in horticulture/tissue culture. Tigst’s current research focuses on detection and identification of genetically modified grains and oilseeds. He also collaborates with the Grain Research Laboratory’s Microbiology program on the use of DNA-based molecular markers for identification and characterization of plant pathogens
Reader, School of Biosciences
Cardiff University, UK
After my BSc in Zoology and Genetics (1986) and my PhD in Evolutionary Genetics (1991) in Cardiff, I moved to Bristol University where my research revealed bone cell gene expression in vivo and implicated glutamatergic signalling in mechanically-induced bone formation. Since appointment in Cardiff University (Lecturer 1996, Senior Lecturer 2009, Reader 2012), I have investigated the role of glutamate transporters in bone, revealed a pathological role for glutamate in arthritis, and identified new pathways of cytokine- and mechanically- induced cartilage degradation. I have secured over £12M of research funding for 30 projects. I act as a manager, and as the Biomechanics, Inflammation and Pain Team Leader in the Arthritis Research UK-funded Centre of Excellence in Biomechanics and Bioengineering at Cardiff. I have supervised 11 PhD/MD students and teach undergraduate students, co-ordinating the Molecular Biology Degree Scheme in Cardiff. I regularly contribute to public engagement with school children, patients and fundraisers.
Team Leader - Analytical Microbiology & Molecular Biology
Mickaël Boyer, PhD, is Analytical Microbiology & Molecular Biology Team Leader for Danone Nutricia Research. From 2003 to 2008, he worked in academic as microbial ecologist (Lyon, France) to study use of plant probiotics as natural fertilizer to stimulate plant health. He developed expertises in molecular biology and microbiology. From 2008 to 2011, he held a scientific position in an academic infectious disease center (Marseille, France) and acquired experience in virology and metagenomic for application in human health. Since 2011, he develops analytical expertises in dairy microbiology to speed up innovation in Danone. He is a professional member of IDF (International Dairy Federation).
Senior Scientist, Cellular Reagents and Assay Development
I am working with assay development within Reagents and Assay Development, Discovery Sciences. Since I joined AstraZeneca two years ago, I have been part of the general movement of replacing artifical cell models with biologically more relevant systems based on primary or native cells. I have been working in target-based projects, as well as phenotypic screening activities. During the last year, my main focus has been adipocytes and quantitative PCR.
Before joining AstraZeneca I did a post-doc on adipocyte biology at Gothenburg University, followed by two years at NovoNordisk, Copenhagen, working with metabolic in-vitro assays.
The Cyprus Institute of Neurology and Genetics, Cyprus
Marios Ioannides is a Researcher at the Translational Genomics Team at the Cyprus Institute of Neurology and Genetics. He had previously worked at the Department of Cytogenetic and Genomics for 7 years and has extensive expertise in a range of molecular diagnostic assays including QFPCR , aCGH and digital PCR. He has also been working on the discovery of fetal specific biomarkers and their implementation in non-invasive prenatal diagnosis.
Adam S. Corner
Senior Field Application Scientist
Adam S. Corner, Ph.D., has been with Raindance Technologies since March 2011, as a Senior Field Applications Scientist. Prior to RainDance Technologies Adam was with Ingenuity Systems (2004-2011) as a Senior Scientist, based in Europe. Before Ingenuity Systems, Adam was with the Application Support group at Applied Biosystems for 7 years. Adam studied for his Batchelor of Science in Biochemistry & Genetics at the University of Leeds, from 1987-1990. He continued at the University of Leeds from 1990-1993, earning a Ph.D. in molecular identification of nematodes.
BTU Cottbus – Senftenberg, Germany
Stefan Rödiger is group leader at the Brandenburg University of Technology Cottbus - Senftenberg. He studied pharma-biotechnology and holds a doctorate in Medical Sciences from the Charité, Berlin. Stefan worked at the University Hospital of Jena (Germay), University Hospital Dresden (Germany), MPI-CBG (Germany) and several small and medium-sized businesses. His research interests cover a broad range of activities including statistical bioinformatics and the development of novel multiparameter diagnostic tools for the accurate measurement of biomolecules from pathogens and autoimmune diseases. He is author of several R packages for the analysis of qPCR data, microbead assays, digital PCR data and melting curve analysis. Current studies focus on statistical bioinformatics for qPCR assays, dPCR assays, multipex real-time PCR microbead-chips and multiparameter diagnostics tools for the highly versatile fluorescence microscope-based VideoScan platform.
Lecturer in Medical Microbiology
Norwich Medical School, University of East Anglia, UK
I gained my B.Sc. in Microbiology, my M.Sc. (Res) in infectious diseases molecular diagnostics and my Ph.D. in molecular diagnosis of bacterial pathogens in food all at the National University of Ireland Galway (NUIG). My early career focussed on the molecular detection of pathogens in food using lab-on-a-chip technology and isothermal amplification based diagnostics. This was followed by a two year stint in industry (Beckman Coulter) developing real-time PCR based molecular diagnostics assays for infectious diseases including Mycobacterium tuberculosis. During my time at Beckman Coulter, I developed a strong interest in tuberculosis (TB) research, which inspired me to move back into academia and take up a post-doc position at University College London on TB diagnostics. In January 2013 I was appointed Lecturer in Medical Microbiology at UEA where I continue my research on microbial pathogen molecular diagnostics with the aim of translating this research broadly, in different sectors and diseases, to maximise community/patient benefit.
Researcher, Laboratory of Experimental Virology
Amsterdam University Medical Center, The Netherlands
Dr. Pasternak received his PhD in Molecular Virology from the Leiden University, Netherlands. From 2006, he works as a Researcher in the Laboratory of Experimental Virology of the Amsterdam University Medical Center. His research focuses on persistence and evolution of HIV-1 reservoir in the face of antiretroviral therapy, in particular the development of sensitive PCR-based quantitative assays for virological biomarkers.
Postdoctoral Research Associate, Cancer Research UK Cambridge Institute
University of Cambridge, UK
Florent completed his PhD from the University of Montpellier (France) in the field of non-invasive biomarkers and was implicated in the characterization of the size and structure of circulating tumour DNA (ctDNA). He was also involved in the development of a Q-PCR based assay for determining KRAS and BRAF mutations in plasma ctDNA. He moved to the Rosenfeld Lab of the Cancer Research UK Cambridge Institute afterwards to start his postdoctoral training, where he now works on exploring the potential of ctDNA as a tool for monitoring the efficacy of new therapeutics and the rise of resistance.
SHGen Wiesbaden Fertility Center, Germany
Dr Angelika Daser studied medicine from 1982 to 1989 in Berlin, Germany, followed by two years training as a doctor in General Surgery.
As a postdoctoral scientist she first focused on Immunology and Immunogenetics at the German Rheumatology Center and the Charité, Berlin from 1991 to 2001.
At the MRC Laboratory of Molecular Biology, Cambridge, UK, she studied Genomics and Genetics of solid tumours and participated in developing mouse models of leukaemias and solid tumours.
Since November 2007, she has been working as Senior Scientist at SH-Gen Research, Wiesbaden, Germany on the development of novel molecular biology techniques to improve pregnancy and take-home baby rates after IVF procedures.
Anna Wilbrey is a post-doctoral scientist at Neusentis, a Pfizer research unit based in Cambridge, United Kingdom. This unit focuses on developing therapies in the areas of pain and sensory disorders, with a particular emphasis on ion channel research. Before joining Pfizer in 2008, Anna completed doctoral studies in Neuroscience in the laboratory of Michael Coleman at the Babraham Institute, also in Cambridge. This work focussed on dissecting the mechanism of Wallerian axonal degeneration and the possible involvement of this process in aging and disease.
qPCR Product Manager
Dr Aurita Menezes began her science education in the field of biochemistry, followed by a PhD in microbiology. For her postdoctoral work, she studied the effects of viral and chemical injury on pulmonary cells. While she has used many molecular techniques throughout her research career, Dr Menezes has developed substantial expertise in performing qPCR and analyzing the data. Dr Menezes joined IDT as a scientific applications specialist, focusing on PrimeTime® qPCR products. She was responsible for qPCR assay design, troubleshooting customer qPCR experiments, and supporting customers in analysis and interpretation of their qPCR data. Currently, Dr Menezes is qPCR Product Manager, responsible for developing the qPCR product portfolio at IDT.
Senior Field Application Scientist
Jim White, PhD. Senior Field Application Specialist with NanoString Technologies for 4 yrs went direct in Europe in 2010. Previously with Life technologies, Biotrove and Applied Biosystems. Experience with technologies involved in Genomics and Proteomics.
University of Ghent, Belgium
Jan Hellemans has a Master in Biotechnology (2000, UGent) and a PhD in Medical Genetics (2007, UGent). He is author of more than 100 scientific articles in international journals, including some pioneering publications in the domain of real-time PCR. Together with Jo Vandesompele, he is active in the development of new concepts and algorithms for improved qPCR data analysis, and one of the founders of the RDML consortium. Jan Hellemans supervised a core facility for automated DNA-isolation, (next generation) sequencing and high-throughput real-time PCR at Ghent university. He is a founder of Biogazelle, active as a teacher in qPCR courses and responsible for qPCR assay development in Biogazelle.
Head of Research and Development
Dr Mark Stevens, co-founder of PCR Biosystems, has 20 years of industrial molecular biology experience. His previous position was Head of R&D at Bioline Reagents Limited. Dr Stevens has expertise in DNA and RNA polymerase enzymology, high-throughput screening, protein biochemistry and enzyme kinetics. Dr Stevens' team was responsible for the R&D of qPCR and endpoint PCR product lines for PCR Biosystems Ltd. For more information see www.pcrbio.com
Associate Professor, Department of Micro- and Nanotechnology
Technical University of Denmark, Denmark
Martin Dufva (MD), holds a faculty position at Technical University of Denmark. He has a PhD degree from the medical faculty and Master degree in Molecular biology both from Göteborg University. He is currently running a group of about 10 persons and is involved as research leader in several national and international projects. He has for a more than a decade worked with DNA and protein microarrays and lately turned into other high throughput platforms including microfluidics droplets and NGS for functional screening of libraries. In parallel to these mainstream high throughput platform he is currently developing a simpler solid phase platform operated using a pipette. The novel platform is especially suitable for diagnostic purposes but is currently being explored for library screening applications and singe cell analysis.
Head of Lab-on-a-Chip Nucleic Acid Analysis, Laboratory for MEMS Applications, IMTEK
University of Freiburg, Germany
Simon Wadle studied biology, majoring in biochemistry and molecular immunology, at the University of Freiburg. During his studies, he also completed a 6 month Erasmus exchange program at the University of Sheffield, Great Britain. In 2009, he finished his studies with a diploma thesis on a microarray-based universal detection method for nucleic acids. For dissertation, he afterwards joined the Lab-on-a-Chip group at the department for MEMS applications (Prof. Zengerle). He is working on the development and microfluidic integration of a universal detection platform for nucleic acids. Since 2014 he is heading the nucleic acid analysis group of the lab-on-a-chip division at the laboratory for MEMS applications.
Team Leader Microfluidics Team
KIST Europe, Germany
Pavel Neuzil obtained his PhD from the Czech Technical University in 1997. He was then a postdoctoral Fellow at the University of Illinois at Chicago, Research Associate at Stanford University. Since then we was a team lead in Institute of Microelectronics and Institute of Bioengineering and Nanotechnology, both in Singapore. Since 2010 he is a team leader at the KIST-Europe, Germany. His research interests evolved from silicon CMOS manufacturing, to MEMS technology and now microfluidics especially for medical diagnostics. He published over 50 scientific papers and he holds over 10 patents. His team developed world smallest real-time PCR system.
Senior Scientist, Digital Biology Centre
Bio Rad Laboratories
Ph.D. in Microbiology from National Chemical Laboratory, Pune, India (2005).
Post doctoral fellow at UC Davis School of Medicine (California)
One of the early Development Staff Scientists of QuantaLife, now Bio-Rad (for 4 years) and witnessed the Successful launch of QX100 ddPCR System and Quanta Life acquisition by Bio-Rad.
New Business Development
Steve Millington has worked for OptiGene since its creation in 2008, prior to this Steve has worked since the late 1990’s on QPCR. During all of this time he has remained focussed on the specific goal to develop portable and rapid analysis and detection, capable of enabling Point of Care testing.
Product Development Manager
Nicky Boulter was awarded her D.Phil in Molecular Parasitology in 1995 from York University, UK, and has over twenty years’ experience in various aspects of molecular biology and microbiology. For most of her professional life, Nicky has worked in infectious disease and parasitology research and has a great interest in these and related fields. She has worked in various environments from further education colleges to universities and the biotech industry, and has undertaken both pure and applied research as well as developing human diagnostics as IVD kits and for use in microfluidic devices. Nicky has numerous publications and patents and also has a Masters in Patent Law. Nicky is currently employed as Product Development Manager with Accugen Pty Ltd in Sydney, and is responsible for development, testing and early commercialisation of AccuCAL, a revolutionary universal calibrator for accurate, absolute quantitation of nucleic acids amplified by qPCR.
Chief Strategy Officer
PhD in Molecular Genetics, University of Geneva, Switzerland, Dr. Gonzalez-Couto has extensive international experience in bioinformatics and sound scientific knowledge in drug development. He has spent his professional career in companies such as Glaxo Wellcome Experimental Research, Geneprot and SienaBiotech, where he was the leader of the "Omics"-based drug discovery efforts in Huntington Disease. He joined Integromics in 2009.
TRON - Translational Oncology
Johannes Gutenberg University of Mainz, Germany
Dr. Claudia Paret is group leader in TRON (Mainz, Germany), a biopharmaceutical research organization that pursues the translation of basic research into drug applications for the treatment of cancer. She studied Chemistry in Torino (Italy) and she obtained in 2001 her PhD in Dresden (Germany) in Molecular Biology with a work focused on copper transport in mitochondrial diseases. From 2002 to 2006 she was working at the German Cancer Research Center in Heidelberg (Germany) on the mechanisms of tumor progression.
Focus of her research in TRON is the identification and validation via high-throughput platforms of tumor specific transcripts for the personalized immunotherapy of solid tumors.
University of Naples Federico II, Italy
Division Vice President, R&D
Abbott Molecular, USA
Science Leader, Nucleic Acid Metrology, Molecular & Cell Biology
Director, Molecular Pharmacology & Pathophysiology
Copyright: Global Engage Ltd. Registered in England. No: 6950636